KRAS and non-small cell lung carcinoma: Epidermal growth factor receptor (EGFR) mutations and anaplastic lymphoma kinase (ALK) rearrangements are more frequent in never-smokers with NSCLC, whereas Kirsten rat sarcoma viral oncogene homolog (KRAS) mutations are associated with ever-smokers [9–11].